Comparison of Positive/Inconclusive Xpert Xpress SARS-CoV-2 with the Standard M nCoV Real-Time Detection

Background: COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can be diag-nosed using rapid real-time PCR, real-time reverse transcription PCR (rRT-PCR), or rapid antigen testing. Among these, rRT-PCR is considered the gold standard assay. The Xpert Xpress SARS-CoV-2 assay is a rapid real-time PCR test, approved by the Korean Disease Control and Prevention Agency in 2020. The overall concor-dance and positive concordance rates of the Xpert assay with the STANDARD M nCoV Real-Time Detection kit were determined. Methods: All samples with positive or inconclusive Xpert test results from July 2021 to February 2023 that under-went confirmatory testing using the reference rRT-PCR assay were included in the analysis. Results: Samples from 224 patients (93 men and 131 women) with a median age of 59 years (range 15 -90 years) were included. Of 212 samples that tested positive using Xpert, 112 (52.8%) were true positves and 100 (47.2%) were false positives on rRT-PCR testing. The overall concordance and positive concordance rates were 52.8% (112/212) and 54.5% (112/224), respectively. In the Xpert positive group, the samples had a lower Ct value for the E gene than the N2 gene. The Ct values for the E and N2 genes were significantly lower in the positive group than in the inconclusive group. Conclusions: Positive or inconclusive Xpert results should be confirmed by the gold standard rRT-PCR for early control of this disease. Furthermore, Korea's policy should be reconsidered given the high false-positive rate of the rapid real-time PCR Xpert Xpress SARS-CoV-2 assay.